DV Biomed Valuation
| 6539 Stock | TWD 66.60 0.20 0.30% |
At this time, the firm appears to be fairly valued. DV Biomed owns a latest Real Value of NT$67.7 per share. The recent price of the firm is NT$66.6. Our model computes the value of DV Biomed from examining the firm fundamentals such as Return On Asset of 8.85, price to sales of 2.22 X, and Current Valuation of 3.68 B as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that DV Biomed's price fluctuation is very steady at this time. Calculation of the real value of DV Biomed is based on 3 months time horizon. Increasing DV Biomed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 6539 stock is determined by what a typical buyer is willing to pay for full or partial control of DV Biomed Co. Since DV Biomed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 6539 Stock. However, DV Biomed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 66.6 | Real 67.7 | Hype 66.6 | Naive 67.64 |
The intrinsic value of DV Biomed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DV Biomed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DV Biomed Co helps investors to forecast how 6539 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DV Biomed more accurately as focusing exclusively on DV Biomed's fundamentals will not take into account other important factors: DV Biomed Total Value Analysis
DV Biomed Co is presently anticipated to have takeover price of 3.68 B with market capitalization of 4.03 B, debt of 249.93 M, and cash on hands of 538.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DV Biomed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.68 B | 4.03 B | 249.93 M | 538.29 M |
DV Biomed Investor Information
The book value of the company was presently reported as 20.43. The company recorded earning per share (EPS) of 5.04. DV Biomed last dividend was issued on the 16th of July 2020. The entity had 1000:345 split on the 27th of June 2024. Based on the measurements of operating efficiency obtained from DV Biomed's historical financial statements, DV Biomed Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.DV Biomed Asset Utilization
One of the ways to look at asset utilization of 6539 is to check how much profit was generated for every dollar of assets it reports. DV Biomed Co utilizes its current and long term assets roughly 8.85 %, securing NT$0.0885 for each dollar of current and long term assets held by the firm. A positive asset utilization denotes the company is slightly more competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of DV Biomed shows how competent it operates for each dollar spent on its current and long term assets.DV Biomed Profitability Analysis
The company reported the revenue of 1.81 B. Net Income was 301.4 M with profit before overhead, payroll, taxes, and interest of 925.51 M.About DV Biomed Valuation
Our relative valuation model uses a comparative analysis of DV Biomed. We calculate exposure to DV Biomed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DV Biomed's related companies.DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct DV Biomed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DV Biomed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DV Biomed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DV Biomed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DV Biomed's revenue streams: Identify DV Biomed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DV Biomed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DV Biomed's growth potential: Evaluate DV Biomed's management, business model, and growth potential.
- Determine DV Biomed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DV Biomed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.